Provider
QP35-18 Pharmacy Benefit Exclusion for Ilumya (tildrakizumab-asmn)
Program effective Date: May 18, 2018
Search Results
Displaying 2881 - 2890 of 3701 results
Provider
QP23-16 Provider Surveys - We Need Your Feedback
Program effective Date: Aug 10, 2016
Provider
QP14-16 July 2016 HCPCS Code Update
Program effective Date: Jun 02, 2016
Provider
QP39-17 Delay of Second Phase Transition with Magellan
Program effective Date: Nov 21, 2017
Provider
QP73-18 Taft Hartley Third Party Administrators and Remote Processing Claims Delays
Program effective Date: Aug 28, 2018
Provider
QP38-17 Protocol for MHCP Subscribers that do not Provide Other Insurance Coverage Information
Program effective Date: Nov 21, 2017
Provider
QP32-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) Criteria: Carbaglu (carglumic acid)
Program effective Date: May 14, 2018
Provider
QP84-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Topiramate Extended Release
Program effective Date: Oct 11, 2018
Provider
QP63-18 Action Required: Apply for Designation as a Blue Distinction Center for Knee and Hip Replacement
Program effective Date: Aug 14, 2018
Provider
QP6-18 Updated Commercial PA Request Form and PA List for Early Intensive Behavioral Intervention Services
Program effective Date: Jan 17, 2018